Maa: Uusi-Seelanti
Kieli: englanti
Lähde: Medsafe (Medicines Safety Authority)
Ergometrine maleate 0.5 mg/mL
Pfizer New Zealand Limited
Ergometrine maleate 0.5 mg/mL
500 mcg/mL
Solution for injection
Active: Ergometrine maleate 0.5 mg/mL Excipient: Maleic acid Water for injection
Ampoule, glass, 5 x 1mL, 5 mL
Prescription
Prescription
Teva Czech Industries s.r.o.
Package - Contents - Shelf Life: Ampoule, glass, 5 x 1mL - 5 mL - 18 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)
1989-09-22
Version: pfdergoi10620 Superseded: Version 5.0 Page 1 of 12 NEW ZEALAND DATA SHEET 1. PRODUCT NAME _ _ DBL ™ Ergometrine Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION DBL ™ Ergometrine Injection consists of ergometrine maleate BP 500 mcg/ml and maleic acid BP in water for injections BP. 3. PHARMACEUTICAL FORM DBL ™ Ergometrine Injection is a colourless or slightly yellowish solution for parenteral use. It is a Solution for injection. The pH range of the injection is 2.7 - 3.5. Ergometrine maleate occurs as a white to greyish-white or faintly yellow, odourless, microcrystalline powder which darkens with age and on exposure to light. The BP states that ergometrine maleate is soluble, and the USP that it is sparingly soluble in water; and slightly soluble in alcohol; practically insoluble in chloroform and ether. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS PROPHYLAXIS Ergometrine is administered after the delivery of the placenta for the purpose of contracting the uterus in order to prevent postpartum haemorrhage and postabortion haemorrhage due to uterine atony. TREATMENT Ergometrine is administered after the delivery of the placenta to promote involution of the uterus in order to treat postpartum haemorrhage and postabortion haemorrhage. 4.2 DOSE AND METHOD OF ADMINISTRATION Ergometrine may be administered by IM or IV injection. However, because the risk of severe adverse effects is increased with IV use of ergometrine, its use via this route is recommended only for emergencies such as excessive uterine bleeding or any other life-threatening situation (see section 4.4). _Prophylaxis of postpartum haemorrhage and postabortion haemorrhage_ Version: pfdergoi10620 Superseded: Version 5.0 Page 2 of 12 The immediate postpartum dose of ergometrine maleate is 200 micrograms administered IM. The injection should not be given until completion of the delivery is assured, and until the possibility of a second twin has been excluded (see section 4.4). In an emergency situation, 200 micrograms may be injec Lue koko asiakirja